Magnetic resonance imaging of regenerating and dystrophic mouse muscle

Biochemistry and Cell Biology

Volumn 76, Issue 2-3, 1998, Pages 532-541

  McIntosh, Laura M ^a,b   Baker, Ross E ^a   Anderson, Judy E ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

mdx mouse; MRI; MRS; Muscle regeneration; Muscular dystrophy; Spectroscopy

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONTROLLED STUDY; CRUSH TRAUMA; DUCHENNE MUSCULAR DYSTROPHY; HINDLIMB; HISTOPATHOLOGY; MUSCLE INJURY; MUSCLE REGENERATION; MUSCULAR DYSTROPHY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RAT; REVIEW;

ANIMALIA;

EID: 0032463050     PISSN: 08298211     EISSN: None     Source Type: Journal    
DOI: 10.1139/o98-033     Document Type: Review

References (61)

1. Anderson, J.E., Ovalle, W.K., and Bressler, B.H. 1987. Electron microscopic and autoradiographic characterization of hind limb muscle regeneration in the mdx mouse. Anat. Rec. 219: 243-257.
2. Anderson, J.E., Bressler, B.H., and Ovalle, W.K. 1988. Functional regeneration in the hind limb skeletal muscle of the mdx mouse. J. Muscle Res. Cell Motil. 9: 499-516.
3. Anderson, J.E., McIntosh, L.M., and Poettcker, R. 1996. Deflazacort but not prednisone improves both muscle repair and fiber growth in diaphragm and limb muscle in vivo in the mdx dystrophic mouse. Muscle Nerve, 19: 1576-1585.
4. Anderson, J.E., Garrett, K., Moor, A., McIntosh, L.M., and Penner, K. 1998. Dystrophy and myogenesis in mdx diaphragm muscle. Muscle Nerve. 21: 1153-1165.
5. Argov, A., and Bank, W.J. 1991. Phosphorus magnetic resonance spectroscopy (31-P MRS) in neuromuscular disorders. Ann. Neurol. 30: 90-97.
6. 1H-NMR spectroscopy for the study of perifused amphibian and excised mammalian muscles. Biochim. Biophys. Acta, 86: 411-424.
7. 1H-NMR of intact muscle at 11T. FEBS Lett. 165: 231-237.
8. Arús, C., Bárány, M., Westler, W.M., and Markley, J.L. 1984b. Proton nuclear magnetic resonance of human muscle extracts. Clin. Physiol. Biochem. 2: 49-55.
9. 1H MR spectroscopy in vivo. Magn. Reson. Med. 10: 210-226.
10. Bieber, F.R., and Hoffman, E.P. 1990. Duchenne and Becker muscular dystrophies: genetics, prenatal diagnosis, and future prospects. Clin. Perintol. 17: 845-865.
11. 13C-uncoupled methyl proton resonance. Magn. Reson. Med. 34: 353-358.
12. 1H spectroscopy of human skeletal muscle: normal and pathological findings. Magn. Reson. Imaging, 10: 957-964.
13. Brown, M.S., and Goldstein, J.L. 1980. Multivalent feedback regulation of HMG-CoA reductase, a control mechanism coordinating isoprenoid synthesis and cell growth. J. Lipid Res. 21: 505-517.
14. Bulfield, G., Siller, W., Wight, P., and Moore, K. 1984. X-chromosome linked muscular dystrophy (mdx) in the mouse. Proc. Natl. Acad. Sci. U.S.A. 81: 1189-1192.
15. Carnwath, J.W., and Shotton, D.M. 1987. Muscular dystrophy in the mdx mouse: histopathology of the soleus and extensor digitorum longus muscles. J. Neurol. Sci. 80: 39-54.
16. Cederbaum, A.I., Qureshi, A., and Cohen, G. 1983. Production of formaldehyde and acetone by hydroxyl-radical generating systems during the metabolism of tertiary butyl alcohol. Biochem. Pharmacol. 32: 3517-3524.
17. Dangain, J., and Vrbova, G. 1984. Muscle development in mdx mutant mice. Muscle Nerve, 7: 700-704.
18. Dunn, J.F., Frostick, S., Brown, G., and Radda, G.K. 1991. Energy status of cells lacking dystrophin: an in vivo - in vitro study of mdx mouse skeletal muscle. Biochim. Biophys. Acta, 106: 115-120.
19. 31P-NMR study of muscle exercise metabolism in mdx mice: evidence for abnormal pH regulation. J. Neurol. Sci. 113: 108-113.
20. 31P-nuclear magnetic resonance study of mdx mice. Proc. R. Soc. Lond. B Biol. Sci. 251: 200-206.
21. Edwards, R.H.T., Dawson, M.J., Wilkie, D.R., Gordon, R.E., and Shaw, D. 1982. Clinical use of nuclear magnetic resonance in the investigation of myopathy. Lancet, 1: 725-731.
22. Fäcke, T., and Berger, S. 1995a. Application of pulsed field gradients in an improved selective TOCSY experiment. J. Magn. Reson. Ser. A, 113: 257-259.
23. Fäcke, T., and Berger, S. 1995b. Complete proton assignment in acetylcholesterol using ge-SELINCOR-TOCSY. Tetrahedron, 51: 3521-3524.
24. 1H-NMR of mdx mouse muscle and myoblast cells during fusion: evidence for a characteristic signal of long chain fatty acids. Neuromusc. Disord. 3: 433-438.
25. Gillet, B., Verré-Sébrié C., Lefaucheur, J.P., Sébille, A., and Beloeil, J.C. 1995. Time course of muscular regeneration assessed by 1H 2D NMR. Proc. Soc. Magn. Reson. 3: 1870.
26. Goldstein, J.L., and Brown, M.S. 1990. Regulation of the mevalonate pathway. Nature (London), 343: 425-430.
27. Grauman, R., Oppelt, A., and Stetter, E. 1986. Multiple spin-echo imaging with a 2D Fourier method. Magn. Reson. Med. 3: 707-721.
28. Griffiths, R.D., Cady, E.B., Edwards, R.H.T., and Wilkie, D.R. 1985. Muscle energy metabolism in Duchenne dystrophy studied by 31-P NMR: controlled trials show no effect of allopurinol or ribose. Muscle Nerve, 8: 760-767.
29. Huang, Y., Majumdar, S., Genant, H.K., Chan, W.P., Sharma, K.R., Yu, P., Mynhier, M., and Miller, R.G. 1994. Quantitative MR relaxometry study of muscle composition and function in Duchenne muscular dystrophy. J. Magn. Reson. Imaging, 4: 59-64.
30. Kemp, G.J., Taylor, D.J., Dunn, J.F., Frostick, S.P., and Radda, G.K. 1993. Cellular energetics of dystrophic muscle. J. Neurol. Sci. 116: 201-206.
31. Kent-Braun, J.A., Miller, R.G., and Weiner, M.W. 1994. Magnetic resonance spectroscopy studies of human muscle. Radiol. Clin. North Am. 32: 313-335.
32. Lamminen, A.E. 1990. Magnetic resonance imaging of primary skeletal muscle diseases: patterns of distribution and severity of involvement. Br. J. Radiol. 63: 946-950.
33. LeRumeur, E., LeTallec, N., Lewa, C.J., Ravalec, X., and deCertaines, J.D. 1995. In vivo evidence of abnormal mechanical and oxidative functions in the exercised muscle of dystrophic hamsters by 31-P NMR. J. Neurol. Sci. 133: 16-23.
34. Matsumura, K., Nakano, I., Fukuda, N., Ikehira, H., Tateno, Y., and Aoki, Y. 1988. Proton spin-lattice relaxation time of Duchenne dystrophy skeletal muscle by magnetic resonance imaging. Muscle Nerve, 11: 97-102.
35. McCully, K.K., Vandenborne, K., Posner, J.D., and Chance, B. 1994. Magnetic resonance spectroscopy of muscle bioenergetics. In NMR in physiology and biomedicine. Edited by R.J. Gillies. Academic Press, Toronto, Ont. pp. 405-412.
36. McGeachie, J.K., and Grounds, M.D. 1987. Initiation and duration of muscle precursor replication after mild and severe injury to skeletal muscle of mice: an autoradiographic study. Cell Tissue Res. 248: 125-130.
37. McIntosh, L.M., Pernitsky, A.N., and Anderson, J.E. 1994. The effects of altered metabolism (hypothyroidism) on muscle repair in the mdx dystrophic mouse. Muscle Nerve, 17: 444-453.
38. McIntosh, L.M., and Anderson, J.E. 1995. Hypothyroidism prolongs and increases mdx muscle precursor proliferation and delays myotube formation in normal and dystrophic limb muscle. Biochem. Cell Biol. 73: 181-190.
39. McIntosh, L.M., Granberg, K.E., Brière, K.M., and Anderson, J.E. 1998a. A nuclear magnetic resonance spectroscopy study of muscle growth, mdx dystrophy and glucocorticoid treatments: correlation with repair. NMR Biomed. 11: 1-10.
40. McIntosh, L.M., Garrett, K.L., Megeney, L., Rudnicki, M.A., and Anderson, J.E. 1998b. Regeneration and myogenic cell proliferation correlate with taurine levels in dystrophin-and myoD-deficient muscles. Anat. Rec. In press.
41. Megeney, L.A., Kablar, B., Garrett, K., Anderson, J.E., and Rudnicki, M.A. 1996. MyoD is required for myogenic stem cell function in adult skeletal muscle. Genes Dev. 10: 1173-1183.
42. Mitchell, C.A., McGeachie, J.K., and Grounds, M.D. 1992. Cellular differences in the regeneration of murine skeletal muscle: a quantitative histological study in SJL/J and BALB/c mice. Cell Tissue Res. 269: 159-166.
43. Murphy, W.A., Totty, W.G., and Carroll, J.E. 1986. MRI of normal and pathologic skeletal muscle. Am. J. Roentgenol. 146: 565-574.
44. Partridge, T.A. 1993. Pathophysiology of muscular dystrophy. Br. J. Hosp. Med. 49: 26-36.
45. Pernitsky, A.N., McIntosh, L.M., and Anderson, J.E. 1996. Hyperthyroidism impairs early repair in normal but not dystrophic mdx mouse tibialis anterior muscle. An in vivo study. Biochem. Cell Biol. 74: 315-324.
46. 1H NMR spectroscopy. Comp. Biochem. Physiol. B, 90: 249-260.
47. Phoenix, J., Betal, D., Roberts, N., Helliwell, T.R., and Edwards, R.H.T. 1996. Objective quantification of muscle and fat in human dystrophic muscle by magnetic resonance imaging analysis. Muscle Nerve, 19: 302-310.
48. Robertson, T.A., Maley, M.A.L., Grounds, M.D., and Papadimitriou, J.M. 1993. The role of macrophages in skeletal muscle regeneration with particular reference to chemotaxis. Exp. Cell Res. 207: 321-331.
49. Schick, F., Eismann, B., Jung, W.I., Bongers, H., Bunse, M., and Lutz, O. 1993. Comparison of localized proton NMR signals of skeletal muscle and fat tissue in vivo: two lipid compartments in muscle tissue. Magn. Reson. Med. 29: 158-167.
50. Shaw, R.A., Mantsch, H.H., and Anderson, J.E. 1996. Infrared spectroscopy of dystrophic mdx mouse muscle distinguishes among treatment groups. J. Appl. Physiol. 81: 2328-2335.
51. Shen, D., Gregory, C.D., and Dawson, M.J. 1996. Observation and quantitation of lactate in oxidative and glycolytic fibers of skeletal muscles. Magn. Reson. Med. 36: 30-38.
52. Stedman, H.H., Sweeney, H.L., Shrager, J.B., Maguire, H.C., Panettieri, R.A., Petrof, B., Narusawa., M., Leferovich, J.M., Sladky, J.T., and Kelly, A.M. 1991. The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature (London), 352: 536-538.
53. Suput, D., Zupan, A., Sepe, A., and Demsar, F. 1992. Magnetic resonance imaging of muscular dystrophies and neuropathies. Basic Appl. Myology, 2: 285-290.
54. Sutherland, G., Peeling, J., Lesiuk, H., and Saunders, J. 1990. Experimental cerebral ischemia studied using nuclear magnetic resonance imaging and spectroscopy. Can. Assoc. Radiol. J. 41: 24-31.
55. Sutherland, G., Lesiuk, H., Hazendonk, P., Peeling, J., Buist, R., Kozlowski, P., Jazinski, A., and Saunders, J.K. 1992. Magnetic resonance imaging and 31P spectroscopy study of the effect of temperature on ischemic brain injury. Can. J. Neurol. Sci. 19: 317-325.
56. Tanguy, O., Bielicki, G., Zanca, M., and Renou, J.P. 1994. A possible way to detect proteolysis in muscular dystrophy by 1H-NMR proton. In Proceedings of the 11th meeting of the European Society of Magnetic Resonance in Biology and Medicine, April 20-24, Vienna, Austria. Edited by Podo et al. Istituto Superiore de Sanita, Rome. p. 158.
57. van Vliet, A.K., Nègre-Aminou, P., van Thiel, G.C.F., Bolhuis, P.A., and Cohen, L.H. 1996. Action of lovostatin, simvastatin, and pravastatin on sterol synthesis and their antiproliferative effect in cultured myoblasts from human striated muscle. Biochem. Pharmacol. 52: 1387-1392.
58. Venkatasubramanian, P.N., Arús, C., and Bárány, M. 1986. Two-dimensional proton magnetic resonance of human muscle extracts. Clin. Physiol. Biochem. 4: 285-292.
59. Vogt, A., Qian, Y., McGuire, T.F., Hamilton, A.D., and Sebti, S.M. Protein geranylgeranyl-ation, not farnesylation, is required for the G1 to S phase transition in mouse fibroblasts. 1996. Oncogene, 13: 1991-1999.
60. Yoshizaki, K., Seo, Y., and Nishikawa, H. 1081. High-resolution proton magnetic resonance spectra of muscle. Biochim. Biophys. Acta, 678: 283-291.
61. 31P-NMR studies in Duchenne muscular dystrophy: age related metabolic changes. Neurology, 37: 165-169.